The COVID-19 vaccine distribution has transitioned from a federal procurement and distribution model to a public/private model. This means that the 2023-2024 vaccines must be obtained through traditional procurement channels. They should be provided to all patients at no cost.
For Providers on the commercial market, the vaccine can be ordered directly through the manufacturer or through a distributor:
Download this fact sheet and guidance on the New Formulation of COVID-19 Vaccines.
For regular updates, please sign up for one of the following sessions:
COVID-19 Vaccine Provider Outreach Team
Los Angeles County Department of Public Health
Vaccine Administration Provider Line -Questions about vaccine distribution, storage and handling, and guidance on registering to receive the vaccine through the CDPH enrollment website.
Vaccine Clinical Provider Line –Clinical questions about COVID-19 vaccines including but not limited to contraindications, precautions, side effects, post vaccination assessment
CDC/CISAvax (Clinical Immunization Safety Assessment Project) - Consults about COVID-19 vaccine safety. Healthcare providers can request a consultation from CISA COVIDvax for a complex COVID-19 vaccine safety question that is (1) about an individual patient residing in the United States or vaccine safety issue and (2) not readily addressed by CDC or Advisory Committee on Immunization Practices (ACIP) guidelines. CISA has vaccine safety subject matter experts in multiple specialties (e.g. ID, allergy/immunology, neurology, OB/GYN, pediatrics, geriatrics)
The Los Angeles County Department of Public Health COVID-19 Data Dashboard enables evaluation of COVID-19 vaccination uptake by number of doses, school district, gender, age, race/ethnicity, and community.
Please visit the dashboard to assess COVID-19 vaccination rates in your area.